This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
- PDA,
- patent ductus arteriosus
- RBF,
- renal blood flow
- RDS,
- respiratory distress syndrome
Abstract
Diuretics are administered routinely to sick neonates for the treatment of multiple clinical disorders, including edema, hypertension, congestive heart failure/cardiovascular disease, bronchopulmonary dysplasia, and renal dysfunction. Choosing the safest and most effective regimen of diuretic therapy for both the term and preterm neonate requires thoughtful consideration of several factors. Such factors include an understanding of each drug’s pharmacologic principles and safety and efficacy profiles as well as outside considerations such as clinically relevant drug interactions and available formulations, among others. This article focuses on the pharmacokinetic and pharmacodynamic characteristics of each of the most commonly employed diuretics in the neonatal population and the factors that may influence the infant’s overall response to therapy.
- Copyright © 2012 by the American Academy of Pediatrics
Individual Login
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
Pay Per Article - You may access this article (from the computer you are currently using) for 2 days for US$25.00
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.
In this issue
Jump to section
Related Articles
Cited By...
- No citing articles found.